Einstein-Ferkauf Researchers Secure $2.5 Million NIH Grant

Researchers to Study Diabetes Self-Management and Behavioral Interventions

More than 25 million Americans have diabetes, yet as many as 60 percent of type 2 diabetes patients do not follow treatment plans prescribed by their health care provider and about 50 percent fail to meet treatment recommendations for control of blood glucose levels. Consistent adherence to oral medications and injectable insulin, both used to keep blood glucose levels in check, is particularly challenging among young patients and ethnic minorities. Consequences are significant: lack of adherence can lead to or exacerbate eye disease, kidney disease and nerve damage.

Dr. Jeffrey Gonzalez

Now, researchers at Yeshiva University’s Albert Einstein College of Medicine and Ferkauf Graduate School of Psychology, and the New York City Department of Health and Mental Hygiene (DOHMH) have been awarded a $2.5 million grant from the National Institutes of Health (NIH) to study a telephone-based approach to improving diabetes self-management and treatment outcomes in primary care.

“People who successfully self-manage their diabetes can reduce their risk for complications, but many patients have trouble sticking with their treatment regimen and making the necessary health behavior changes,” said Jeffrey Gonzalez, Ph.D., assistant professor of psychology at Ferkauf and assistant professor of medicine and of epidemiology & population health at Einstein. “One of our goals is to develop a treatment strategy that can be widely used in clinical practice to support patients with diabetes in their efforts to make changes and adhere to their regimen. We also want to learn whether this intervention can help reduce emotional distress related to diabetes, a common problem that often goes along with self-management difficulties.” Read more at Einstein News